Russia has announced a breakthrough in cancer research, described as a “ray of hope” for millions of patients. A new mRNA-based vaccine called Enteromix has shown 100% success in early trials, shrinking tumors in colorectal cancer patients without causing major side effects.
The start of the clinical trial was revealed on the St. Petersburg International Economic Forum 2025, where Russian health officials presented the findings to international delegates.
Enteromix is developed by Russia’s National Medical Research Radiological Centre in partnership with the Engelhardt Institute of Molecular Biology. It uses the same mRNA technology that helped create COVID-19 vaccines, but instead of fighting a virus, it teaches the body’s immune system how to recognize and destroy cancer cells.
“Traditional treatments like chemotherapy often damage healthy cells and cause painful side effects,” explained Dr. Veronika Skvortsova, head of Russia’s Federal Medical and Biological Agency. “Enteromix works differently. It is a smart vaccine that is designed for each individual patient, based on the unique genetics of their tumor. That is why the results are so powerful.”
The vaccine was tested on 48 volunteers suffering from colorectal cancer. Doctors say that all patients responded positively. Tumors were reduced in size, their growth slowed down, and no dangerous complications were reported.
“After years of watching chemotherapy weaken patients, it is inspiring to see a treatment that works with the body, not against it,” said one of the lead researchers during the forum.
Patients also reported feeling stronger and able to continue daily life with less disruption. “For the first time, I felt my body was fighting back,” shared one patient, according to Russian media reports.
Cancer vaccines have been studied for decades, but most failed because they were not specific enough. Enteromix is different because it is fully personalized. Each dose is made for the individual patient, targeting only their tumor cells. This precision makes it safer and more effective.
The use of mRNA technology also allows faster development of new versions. Russian scientists are already preparing vaccines for brain cancer (glioblastoma) and skin cancer (melanoma).
“This is not just another cancer drug,” said Skvortsova. “It is the beginning of a new era of medicine, where treatments are personal, safe, and built with cutting-edge science.”
Experts warn that early trials are only the beginning. Larger studies involving thousands of patients are required before Enteromix can be approved for worldwide use.
Medical experts outside Russia also urged caution. “We must not celebrate too early,” said Dr. Michael Lane, an oncologist in London. “The results are promising, but until phase two and phase three trials confirm safety and effectiveness, this vaccine cannot be considered a global solution.”
As Enteromix must be customized for each patient, it requires advanced genetic testing and strict cold storage similar to COVID vaccines. This makes large-scale distribution difficult and expensive.
Despite these issues, Russia has promised that once approved, Enteromix will be given free of charge to patients in the country.
The news has drawn attention from around the world. Countries with high cancer rates, such as India, are watching closely. For millions of patients in regions where access to advanced treatments is limited, Enteromix could be life-changing.
“If Russia’s results are confirmed, it would open a new chapter in cancer treatment,” said Dr. Priya Menon, a cancer researcher in New Delhi. “But affordability and access must be addressed, or this will remain a treatment only for the rich.”
“The fight against cancer has always felt endless,” one patient reportedly told doctors. “But this vaccine gave me hope that we are finally moving in the right direction.”
The Russian Ministry of Health says it is ready to move forward with regulatory approvals and expanded trials. If cleared, Enteromix could become the world’s first personalized mRNA cancer vaccine.
How can I get this vaccine for my mother..she is liver cancer patient.. please